These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 9364350

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Growth and management of short stature in thalassaemia major.
    Theodoridis C, Ladis V, Papatheodorou A, Berdousi H, Palamidou F, Evagelopoulou C, Athanassaki K, Konstantoura O, Kattamis C.
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():835-44. PubMed ID: 10091154
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Growth and puberty and its management in thalassaemia.
    De Sanctis V.
    Horm Res; 2002; 58 Suppl 1():72-9. PubMed ID: 12373018
    [Abstract] [Full Text] [Related]

  • 5. Short stature and failure of pubertal development in thalassaemia major: evidence for hypothalamic neurosecretory dysfunction of growth hormone secretion and defective pituitary gonadotropin secretion.
    Roth C, Pekrun A, Bartz M, Jarry H, Eber S, Lakomek M, Schröter W.
    Eur J Pediatr; 1997 Oct; 156(10):777-83. PubMed ID: 9365067
    [Abstract] [Full Text] [Related]

  • 6. Growth and endocrine function in thalassemia major in childhood and adolescence.
    Delvecchio M, Cavallo L.
    J Endocrinol Invest; 2010 Jan; 33(1):61-8. PubMed ID: 20203539
    [Abstract] [Full Text] [Related]

  • 7. Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency.
    Cavallo L, Gurrado R, Zecchino C, Manolo F, De Sanctis V, Cisternino M, Caruso-Nicoletti M, Galati M.
    J Pediatr Endocrinol Metab; 1998 Jan; 11 Suppl 3():845-9. PubMed ID: 10091155
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Endocrine complications in patients with Thalassaemia Major.
    Toumba M, Sergis A, Kanaris C, Skordis N.
    Pediatr Endocrinol Rev; 2007 Dec; 5(2):642-8. PubMed ID: 18084158
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The multifactorial origin of growth failure in thalassaemia.
    Skordis N, Kyriakou A.
    Pediatr Endocrinol Rev; 2011 Mar; 8 Suppl 2():271-7. PubMed ID: 21705977
    [Abstract] [Full Text] [Related]

  • 13. Final adult height and endocrine complications in young adults with β-thalassemia major (TM) who received oral iron chelation (OIC) in comparison with those who did not use OIC.
    Soliman AT, Yassin MA, De Sanctis V.
    Acta Biomed; 2018 Feb 16; 89(2-S):27-32. PubMed ID: 29451226
    [Abstract] [Full Text] [Related]

  • 14. Growth deficiency in polytransfused beta-thalassaemia patients is not growth hormone dependent.
    Cavallo L, Gurrado R, Gallo F, Zacchino C, De Mattia D, Tatò L.
    Clin Endocrinol (Oxf); 1997 Jun 16; 46(6):701-6. PubMed ID: 9274700
    [Abstract] [Full Text] [Related]

  • 15. [Growth and endocrine function in major thalassemia].
    Pérignon F, Brauner R, Souberbielle JC, de Montalembert M, Girot R.
    Arch Fr Pediatr; 1993 Oct 16; 50(8):657-63. PubMed ID: 8002739
    [Abstract] [Full Text] [Related]

  • 16. Impact of long-term iron chelation therapy on growth and endocrine functions in thalassaemia.
    De Sanctis V, Roos M, Gasser T, Fortini M, Raiola G, Galati MC, Italian Working Group on Endocrine Complications in Non-Endocrine Diseases.
    J Pediatr Endocrinol Metab; 2006 Apr 16; 19(4):471-80. PubMed ID: 16759032
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Multicentre study on prevalence of endocrine complications in thalassaemia major. Italian Working Group on Endocrine Complications in Non-endocrine Diseases.
    Clin Endocrinol (Oxf); 1995 Jun 16; 42(6):581-6. PubMed ID: 7634497
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of oral and subcutaneous iron chelation therapies in the prevention of major endocrinopathies in beta-thalassemia major patients.
    Wang CH, Wu KH, Tsai FJ, Peng CT, Tsai CH.
    Hemoglobin; 2006 Jun 16; 30(2):257-62. PubMed ID: 16798651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.